These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16467680)

  • 41. [Anti-infectious effect of sustained antravitreal amphotericin B drug delivery system on experimental rabbit fungal endophthalmitis of Candida albicans].
    Chen N; Yang YT; Dong XG; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2006 May; 42(5):420-5. PubMed ID: 16762236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Intraocular implantation of cyclosporine A drug delivery system in the treatment of experimental uveitis].
    Dong XG; Xu YM; Yuan GQ; Shi WY; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2005 Jul; 41(7):636-41. PubMed ID: 16080900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
    Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.
    Khanum BNMK; Guha R; Sur VP; Nandi S; Basak SK; Konar A; Hazra S
    Eye (Lond); 2017 Sep; 31(9):1317-1328. PubMed ID: 28304388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Biodegradable Scleral Plugs Containing Curcumin on Proliferative Vitreoretinopathy.
    Zhang J; Zhou N; Zhang B; Ma J
    Ophthalmic Res; 2018; 59(1):30-36. PubMed ID: 28942445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravitreal Tissue Plasminogen Activator Injection for the Treatment of Proliferative Vitreoretinopathy in a Rabbit Model.
    Reitblat O; Barayev E; Gal-Or O; Tsessler M; Dotan A
    Ophthalmic Res; 2023; 66(1):48-56. PubMed ID: 35772382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: feasibility in prevention of proliferative vitreoretinopathy.
    Kimura H; Sakamoto T; Cardillo JA; Spee C; Hinton DR; Gordon EM; Anderson WF; Ryan SJ
    Hum Gene Ther; 1996 May; 7(7):799-808. PubMed ID: 8860832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravitreal decorin preventing proliferative vitreoretinopathy in perforating injuries: a pilot study.
    Abdullatif AM; Macky TA; Abdullatif MM; Nassar K; Grisanti S; Mortada HA; Soliman MM
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2473-2481. PubMed ID: 30128605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy.
    Cardillo JA; Farah ME; Mitre J; Morales PH; Costa RA; Melo LA; Kuppermann B; Jorge R; Ashton P
    Br J Ophthalmol; 2004 Sep; 88(9):1201-5. PubMed ID: 15317716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The upregulation of zinc finger protein 670 and prostaglandin D2 synthase in proliferative vitreoretinopathy.
    Kuo HK; Chen YH; Huang F; Wu YC; Shiea J; Wu PC
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):205-13. PubMed ID: 25940552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene. Can proliferative vitreoretinopathy be a target of gene therapy?
    Sakamoto T; Kimura H; Scuric Z; Spee C; Gordon EM; Hinton DR; Anderson WF; Ryan SJ
    Ophthalmology; 1995 Oct; 102(10):1417-24. PubMed ID: 9097787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin.
    Er H; Turkoz Y; Mizrak B; Parlakpinar H
    Ophthalmologica; 2006; 220(1):17-22. PubMed ID: 16374044
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy.
    Lei H; Velez G; Hovland P; Hirose T; Kazlauskas A
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):42-8. PubMed ID: 18172073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies.
    Moon SW; Sun Y; Warther D; Huffman K; Freeman WR; Sailor MJ; Cheng L
    Drug Deliv; 2018 Jan; 25(1):600-610. PubMed ID: 29461171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Efficacy of 5-fluorouracil polyactic acid microsphere in prevention of proliferative vitreoretinopathy].
    Bi HS; Cui Y; Zhang JH; Wang XR; Xie XF
    Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):37-41. PubMed ID: 16638279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alteration of glutamine concentration in the vitreous humor in patients with proliferative vitreoretinopathy.
    Ishikawa S; Nakazawa M; Ishikawa A; Ishiguro S; Tamai M
    Curr Eye Res; 1995 Mar; 14(3):191-7. PubMed ID: 7796602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of experimental proliferative vitreoretinopathy by sustained intraocular delivery of 5-FU.
    Borhani H; Peyman GA; Rahimy MH; Thompson H
    Int Ophthalmol; 1995; 19(1):43-9. PubMed ID: 8537196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.